HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 397-408 of 1,811
Other study type icon
Enrolling By InvitationNCT05841212

DBT Skills Group for Adolescents with ADHD

Official study title

The Acceptability and Feasibility of Implementing a Dialectical Behaviour Therapy (DBT) Skills Group for Adolescents with ADHD

This study is by invitation only.

In London
ADHDInterventional studyAges 13–16
Countries
United Kingdom
Sponsor
King's College London (University)
Behavioral study icon
Enrolling By InvitationNCT06457256

Hybrid Effectiveness-Implementation study of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico

Official study title

Hybrid Effectiveness-Implementation Trial of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico (CLS-A-FUERTE)

This study is by invitation only.

Multiple locations, including San Francisco
ADHDBehavioural studyAges 5+
Countries
United States, Mexico
Sponsor
University of California, San Francisco
Drug study icon
CompletedNCT00856063

Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

Feasibility and Utility of Autonomic Correlates of Impulsivity in Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD): Extending Translational Research Skills

This study has finished and is no longer accepting participants.

Location not clearly listed
ADHDMedication studyAges 48–70 months
Countries
Sponsor
University of Arizona
Device study icon
CompletedNCT03844269

Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01

Official study title

A Study to Assess Midline Frontal Theta (MFT) Power as Measured by Stimulus-locked Electroencephalography (EEG) Before and After AKL-T01 Treatment for Improving Attention in Pediatric Participants Ages 8-12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In San Rafael
ADHDDevice studyAges 8–12
Countries
United States
Sponsor
Akili Interactive Labs, Inc.
Drug study icon
CompletedNCT03605680

A study Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Official study title

A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

In New York
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.